DexCom, Inc. (DXCM)
90.82
+1.53
(+1.71%)
USD |
NASDAQ |
Aug 28, 16:00
90.88
+0.06
(+0.07%)
After-Hours: 20:00
DexCom Cash and Short Term Investments (Quarterly) : 1.947B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.947B |
| March 31, 2026 | 2.415B |
| December 31, 2025 | 1.999B |
| September 30, 2025 | 3.322B |
| June 30, 2025 | 2.929B |
| March 31, 2025 | 2.701B |
| December 31, 2024 | 2.579B |
| September 30, 2024 | 2.492B |
| June 30, 2024 | 3.121B |
| March 31, 2024 | 2.897B |
| December 31, 2023 | 2.724B |
| September 30, 2023 | 3.240B |
| June 30, 2023 | 3.636B |
| March 31, 2023 | 2.567B |
| December 31, 2022 | 2.456B |
| September 30, 2022 | 2.372B |
| June 30, 2022 | 2.755B |
| March 31, 2022 | 2.688B |
| December 31, 2021 | 2.731B |
| September 30, 2021 | 2.698B |
| June 30, 2021 | 2.585B |
| March 31, 2021 | 2.633B |
| December 31, 2020 | 2.708B |
| September 30, 2020 | 2.604B |
| June 30, 2020 | 2.509B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.510B |
| December 31, 2019 | 1.533B |
| September 30, 2019 | 1.430B |
| June 30, 2019 | 1.378B |
| March 31, 2019 | 1.358B |
| December 31, 2018 | 1.386B |
| September 30, 2018 | 668.70M |
| June 30, 2018 | 606.10M |
| March 31, 2018 | 533.90M |
| December 31, 2017 | 548.60M |
| September 30, 2017 | 525.80M |
| June 30, 2017 | 496.60M |
| March 31, 2017 | 181.10M |
| December 31, 2016 | 123.70M |
| September 30, 2016 | 127.30M |
| June 30, 2016 | 115.60M |
| March 31, 2016 | 106.50M |
| December 31, 2015 | 115.20M |
| September 30, 2015 | 113.30M |
| June 30, 2015 | 97.50M |
| March 31, 2015 | 83.80M |
| December 31, 2014 | 83.60M |
| September 30, 2014 | 74.90M |
| June 30, 2014 | 61.30M |
| March 31, 2014 | 57.40M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Abbott Laboratories | 5.603B |
| Insulet Corp. | 534.90M |
| Baxter International, Inc. | 2.15B |
| Globus Medical, Inc. | 595.14M |
| Stryker Corp. | 3.476B |